Since the penetrance of the RNF213 p.Arg4810Lys variant for moyamoya disease and PAH is quite low in human studies, the RNF213 p.Arg4810Lys variant is considered a susceptibility gene variant, and carriers may need a second-hit factor to develop vasculopathy. Here, RNF213 is linked to Moyamoya disease.